Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • DiNardo, CD; Stein, EM; de Botton, S; Roboz, GJ; Altman, JK; Mims, AS; Swords, R; Collins, RH; Mannis, GN; Pollyea, DA; Donnellan, W; Fathi, AT; Pigneux, A; Erba, HP; Prince, GT; Stein, AS; Uy, GL; Foran, JM; Traer, E; Stuart, RK; Arellano, ML; Slack, JL; Sekeres, MA; Willekens, C; Choe, S; Wang, H; Zhang, V; Yen, KE; Kapsalis, SM; Yang, H; Dai, D; Fan, B; Goldwasser, M; Liu, H; Agresta, S; Wu, B; Attar, EC; Tallman, MS; Stone, RM; Kantarjian, HM

Published Date

  • September 2018

Published In

Volume / Issue

  • 18 /

Start / End Page

  • S204 - S205

Published By

International Standard Serial Number (ISSN)

  • 2152-2650

Digital Object Identifier (DOI)

  • 10.1016/j.clml.2018.07.057